CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 2	$ 6
Operating expenses:
Research and development	469	143	1,002	448
General and administrative	718	1,007	2,318	3,615
Total operating expenses	1,187	1,150	3,320	4,063
Loss from operations	(1,187)	(1,150)	(3,318)	(4,057)
Other income (expense):
Change in fair value of warrant liability	0		(31)	0
Other income, net	28	23	66	120
Other income (expense), net	28	23	35	120
Net loss	$ (1,159)	$ (1,127)	$ (3,283)	$ (3,937)
Earnings per share, Basic	$ (0.55)	$ (0.7)	$ (1.84)	$ (2.46)
Earnings per share, Diluted	$ (0.55)	$ (0.7)	$ (1.84)	$ (2.46)
Weighted average common shares outstanding, basic	2,183,039	1,601,252	1,822,500	1,601,252
Weighted average common shares outstanding, diluted	2,183,039	1,601,252	1,822,500	1,601,252